Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.52 |
| ▸ | HPGD | P15428 | 5/20 | 0.52 |
| ▸ | RAB9A | P51151 | 4/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | HTT | P42858 | 2/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 5/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.48 |
| ▸ | RECQL | P46063 | 1/20 | 0.48 |
| ▸ | ATM | Q13315 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.47 |
| ▸ | MAPK12 | P53778 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1615179 | 0.92 | ALDH1A1 (0.65) | ALDH1A1L3MBTL1HPGDRAB9ASMN1; SMN2 | |
| SCHEMBL6842263 | 0.87 | ALDH1A1 (0.66) | RXFP1ALDH1A1L3MBTL1HPGDRAB9A | |
| SCHEMBL10055051 | 0.84 | RXFP1 (0.56) | RXFP1ALDH1A1L3MBTL1HPGDRAB9A | |
| SCHEMBL1663456 | 0.84 | HCAR3 (0.55) | RXFP1ALDH1A1L3MBTL1HPGDSMN1; SMN2 | |
| SCHEMBL14830545 | 0.84 | ALDH1A1 (0.50) | RXFP1ALDH1A1L3MBTL1HPGDRAB9A | |
| SCHEMBL6841746 | 0.83 | KMT2A (0.55) | RXFP1ALDH1A1RAB9AHTTNPSR1 | |
| SCHEMBL29102032 | 0.83 | RXFP1 (0.50) | RXFP1ALDH1A1L3MBTL1HPGDRAB9A | |
| SCHEMBL13841105 | 0.83 | HSD17B10 (0.51) | RXFP1ALDH1A1L3MBTL1RAB9ASMN1; SMN2 | |
| SCHEMBL10024338 | 0.83 | RXFP1 (0.50) | RXFP1ALDH1A1L3MBTL1HPGDRAB9A | |
| SCHEMBL24611718 | 0.82 | PARP10 (0.51) | RXFP1ALDH1A1HPGDRAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 201 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11382868-B2 | Transdermal UV-curable hydrogel resin, hydrogel curing the same and cataplasm containing the same | ICURE PHARMACEUTICAL INC. (KR) | 2022-07-12 | — | — | US | claimed |
| EP-3200754-B1 | COSMETIC PROCESS FOR ATTENUATING WRINKLES | OREAL (FR) | 2020-06-10 | — | — | EP | claimed |
| US-20190046463-A1 | ULTRAVIOLET-HARDENING HYDROGEL RESIN AND HYDROGEL FOR TRANSDERMAL ADMINISTRATION, AND CATAPLASM AGENT CONTAINING SAME | ICURE PHARMACEUTICAL INC. (KR) | 2019-02-14 | — | — | US | claimed |
| EP-3415141-A1 | ULTRAVIOLET-HARDENING HYDROGEL RESIN AND HYDROGEL FOR TRANSDERMAL ADMINISTRATION, AND CATAPLASM AGENT CONTAINING SAME | Icure Pharmaceutical Inc. (KR) | 2018-12-19 | — | — | EP | claimed |
| US-20180044560-A1 | HIGH TEMPERATURE STABLE, LOW OUTGASSING COMPOSITION, PROTECTIVE TAPE COMPRISING SUCH COMPOSITION AND USE OF SUCH TAPE WITH THIN GLASS | CORNING INC (US) | 2018-02-15 | — | — | US | claimed |
| EP-3200754-A1 | COSMETIC PROCESS FOR ATTENUATING WRINKLES | L'OREAL (FR) | 2017-08-09 | — | — | EP | claimed |
| US-20170209360-A1 | COSMETIC PROCESS FOR ATTENUATING WRINKLES | L'OREAL (FR) | 2017-07-27 | — | — | US | claimed |
| WO-2016050793-A1 | COSMETIC PROCESS FOR ATTENUATING WRINKLES | L'OREAL (FR) | 2016-04-07 | — | — | WO | claimed |
| US-20070232714-A1 | Device having low outgassing photo or electron beam curable rubbery polymer material | CORNING INCORPORATED | 2007-10-04 | — | — | US | claimed |
| EP-1817390-A2 | DEVICE COMPRISING LOW OUTGASSING PHOTO OR ELECTRON BEAM CURED RUBBERY POLYMER MATERIAL | Corning Incorporated (US) | 2007-08-15 | — | — | EP | claimed |
| US-7232595-B2 | Device comprising low outgassing photo or electron beam cured rubbery polymer material | CORNING INCORPORATED (US) | 2007-06-19 | — | — | US | claimed |
| WO-2006060592-A2 | DEVICE COMPRISING LOW OUTGASSING PHOTO OR ELECTRON BEAM CURED RUBBERY POLYMER MATERIAL | CORNING INCORPORATED (US) | 2006-06-08 | — | — | WO | claimed |
| US-20050152595-A1 | Device comprising low outgassing photo or electron beam cured rubbery polymer material | CORNING INCORPORATED | 2005-07-14 | — | — | US | claimed |
| US-6797841-B2 | HAVING PHOTOINITIATION ACTIVITY WITH MINIMAL OR NO ADVERSE HAZARDOUS CHARACTERISTICS | ALBEMARLE CORPORATION | 2004-09-28 | — | — | US | claimed |
| US-6762323-B2 | EXPOSING A FORMUALTION CONTAINING A PIGMENT AND A PHOTOPOLYMERIZABLE COMPOUND HAVING AN ETHYLENICALLY UNSATURATED DOUBLE BOND TO RADIATION IN PRESENCE NON-MUTAGENIC PHOTOINITIATOR | ALBEMARLE CORPORATION | 2004-07-13 | — | — | US | claimed |
| US-20040092618-A1 | Low outgassing photo or electron beam curable rubbery polymer material, preparation thereof and device comprising same | CORNING INCORPORATED | 2004-05-13 | — | — | US | claimed |
| US-20040054244-A1 | Process of quadricyclane production | EXCITON, INC. | 2004-03-18 | — | — | US | claimed |
| US-20030078313-A1 | Aminobenzophenones and photopolymerizable compositions including the same | ALBEMARLE CORPORATION | 2003-04-24 | — | — | US | claimed |
| US-20030065049-A1 | Aminobenzophenones and photopolymerizable compositions including the same | ALBEMARLE CORPORATION | 2003-04-03 | — | — | US | claimed |
| US-6479706-B1 | Aminobenzophenones and photopolymerizable compositions including the same | ALBEMARLE CORPORATION | 2002-11-12 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170209360-A1 | COSMETIC PROCESS FOR ATTENUATING WRINKLES | CUTA, MC1R, GLA | RXFP1 1118/4885ALDH1A1 1493/4885L3MBTL1 3757/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.